Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 380


Dose-dependent neutralizing-antibody responses to vaccinia.

Belshe RB, Newman FK, Frey SE, Couch RB, Treanor JJ, Tacket CO, Yan L.

J Infect Dis. 2004 Feb 1;189(3):493-7. Epub 2004 Jan 23.


Clinical and immunological responses to undiluted and diluted smallpox vaccine with vaccinia virus of Lister strain.

Hsieh SM, Chen SY, Sheu GC, Hung MN, Chou WH, Chang SC, Hsu KH.

Vaccine. 2006 Jan 23;24(4):510-5. Epub 2005 Aug 18.


Dose-related effects of smallpox vaccine.

Frey SE, Newman FK, Cruz J, Shelton WB, Tennant JM, Polach T, Rothman AL, Kennedy JS, Wolff M, Belshe RB, Ennis FA.

N Engl J Med. 2002 Apr 25;346(17):1275-80. Epub 2002 Mar 28.


Clinical responses to smallpox vaccine in vaccinia-naive and previously vaccinated populations: undiluted and diluted Lancy-Vaxina vaccine in a single-blind, randomized, prospective trial.

Kim SH, Yeo SG, Jang HC, Park WB, Lee CS, Lee KD, Kim HB, Kim NJ, Kim YT, Jee Y, Cho H, Oh MD, Choe KW.

J Infect Dis. 2005 Sep 15;192(6):1066-70. Epub 2005 Aug 11.


Reducing the dose of smallpox vaccine reduces vaccine-associated morbidity without reducing vaccination success rates or immune responses.

Couch RB, Winokur P, Edwards KM, Black S, Atmar RL, Stapleton JT, Kissner JM, Shinefield H, Denny TN, Bybel MJ, Newman FK, Yan L; National Institute of Allergy and Infectious Diseases Smallpox Vaccine Study Group.

J Infect Dis. 2007 Mar 15;195(6):826-32. Epub 2007 Feb 5.


Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine.

Newman FK, Frey SE, Blevins TP, Mandava M, Bonifacio A Jr, Yan L, Belshe RB.

J Clin Microbiol. 2003 Jul;41(7):3154-7.


A novel, cell culture-derived smallpox vaccine in vaccinia-naive adults.

Artenstein AW, Johnson C, Marbury TC, Morrison D, Blum PS, Kemp T, Nichols R, Balser JP, Currie M, Monath TP.

Vaccine. 2005 May 9;23(25):3301-9.


Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus dissemination.

Grosenbach DW, Jordan R, King DS, Berhanu A, Warren TK, Kirkwood-Watts DL, Tyavanagimatt S, Tan Y, Wilson RL, Jones KF, Hruby DE.

Vaccine. 2008 Feb 13;26(7):933-46. doi: 10.1016/j.vaccine.2007.11.095. Epub 2007 Dec 26.


Response to smallpox vaccine in persons immunized in the distant past.

Frey SE, Newman FK, Yan L, Lottenbach KR, Belshe RB.

JAMA. 2003 Jun 25;289(24):3295-9. Erratum in: JAMA. 2003 Jul 16;290(3):334.


Clinical and immunological comparison of smallpox vaccine administered to the outer versus the inner upper arms of vaccinia-naive adults.

Waibel KH, Golding H, Manischewitz J, King LR, Tuchscherer M, Topolski RL, Walsh DS.

Clin Infect Dis. 2006 Feb 15;42(4):e16-20. Epub 2006 Jan 10.


Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.

Meseda CA, Garcia AD, Kumar A, Mayer AE, Manischewitz J, King LR, Golding H, Merchlinsky M, Weir JP.

Virology. 2005 Sep 1;339(2):164-75.


Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults.

Frey SE, Newman FK, Kennedy JS, Ennis F, Abate G, Hoft DF, Monath TP.

Vaccine. 2009 Mar 4;27(10):1637-44. doi: 10.1016/j.vaccine.2008.11.079. Epub 2008 Dec 9.


Clinical responses to undiluted and diluted smallpox vaccine.

Frey SE, Couch RB, Tacket CO, Treanor JJ, Wolff M, Newman FK, Atmar RL, Edelman R, Nolan CM, Belshe RB; National Institute of Allergy and Infectious Diseases Smallpox Vaccine Study Group.

N Engl J Med. 2002 Apr 25;346(17):1265-74. Epub 2002 Mar 28.


Gender effects on humoral immune responses to smallpox vaccine.

Kennedy RB, Ovsyannikova IG, Pankratz VS, Vierkant RA, Jacobson RM, Ryan MA, Poland GA.

Vaccine. 2009 May 26;27(25-26):3319-23. doi: 10.1016/j.vaccine.2009.01.086. Epub 2009 Feb 5.


Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults.

Treanor J, Wu H, Liang H, Topham DJ.

Vaccine. 2006 Nov 17;24(47-48):6913-23. Epub 2006 Jun 21.


Accuracy and repeatability of a micro plaque reduction neutralization test for vaccinia antibodies.

Borges MB, Kato SE, Damaso CR, Moussatché N, da Silva Freire M, Lambert Passos SR, do Nascimento JP.

Biologicals. 2008 Mar;36(2):105-10. Epub 2007 Sep 24.


Determination of immunity to vaccinia virus by using diluted inactivated vaccinia vaccine solution for skin testing.

Somekh E, Smetana Z, Tanay A, Dalal I, Babai I, Mendelson E.

Vaccine. 2004 Dec 2;23(3):321-4.


Phase II randomized, double-blinded comparison of a single high dose (5×10(8) TCID50) of modified vaccinia Ankara compared to a standard dose (1×10(8) TCID50) in healthy vaccinia-naïve individuals.

Frey SE, Winokur PL, Hill H, Goll JB, Chaplin P, Belshe RB.

Vaccine. 2014 May 13;32(23):2732-9. doi: 10.1016/j.vaccine.2014.02.043. Epub 2014 Mar 6.


Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults.

Kennedy JS, Gurwith M, Dekker CL, Frey SE, Edwards KM, Kenner J, Lock M, Empig C, Morikawa S, Saijo M, Yokote H, Karem K, Damon I, Perlroth M, Greenberg RN.

J Infect Dis. 2011 Nov;204(9):1395-402. doi: 10.1093/infdis/jir527. Epub 2011 Sep 15.


Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination.

Kennedy JS, Frey SE, Yan L, Rothman AL, Cruz J, Newman FK, Orphin L, Belshe RB, Ennis FA.

J Infect Dis. 2004 Oct 1;190(7):1286-94. Epub 2004 Aug 30.

Items per page

Supplemental Content

Write to the Help Desk